Pathogenetic treatment for neurotrophic keratopathy
Introduction. Continuous soft contact lens (SCL) wearing can result in development of neurotrophic keratopathy. Treatment of this pathology is long-term and, in general, symptomatic: tear-substitute, epithelizing, vitaminous, antibacterial, anti-inflammatory therapy. Purpose. To improve a correc...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ukrainian Society of Ophthalmologists
2018-04-01
|
| Series: | Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://www.ozhurnal.com/en/archive/2018/2/2-fulltext |
| _version_ | 1797376498086182912 |
|---|---|
| author | T. B. Gaidamaka T. A. Veliksar G. I. Drozhzhyna T. M. Serebrina |
| author_facet | T. B. Gaidamaka T. A. Veliksar G. I. Drozhzhyna T. M. Serebrina |
| author_sort | T. B. Gaidamaka |
| collection | DOAJ |
| description | Introduction. Continuous soft contact lens (SCL) wearing can result in development of neurotrophic keratopathy. Treatment of this pathology is long-term and, in general, symptomatic: tear-substitute, epithelizing, vitaminous, antibacterial, anti-inflammatory therapy.
Purpose. To improve a correction method for metabolic alterations in corneal tissues in continuous-SCL-wear-associated neurotrophic keratopathy through using transorbital electrophoresis with 1% thiotriazoline.
Material and Methods. We developed a method of treatment for neurotrophic keratopathy which includes a 10 day course of daily transorbital electrophoresis with 1% thiotriazoline as a part of complex therapy. We applied for approval of Author's certificate (application No U 201710621 dated 01 November 2017).
Results. Clinical cases of treatment of stage 1 neurotrophic keratopathy are reported.
Conclusion. The proposed treatment enables in a short term to significantly decrease pathological changes in corneal tissues in stage 1 neurotrophic keratopathy, to increase comfort in the eyes, to prevent severe complications of neurotrophic keratopathy and soft contact lens wearing. |
| first_indexed | 2024-03-08T19:39:29Z |
| format | Article |
| id | doaj.art-7f1173a321e24721b2ab717892135215 |
| institution | Directory Open Access Journal |
| issn | 2412-8740 |
| language | English |
| last_indexed | 2024-03-08T19:39:29Z |
| publishDate | 2018-04-01 |
| publisher | Ukrainian Society of Ophthalmologists |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj.art-7f1173a321e24721b2ab7178921352152023-12-25T10:49:02ZengUkrainian Society of OphthalmologistsJournal of Ophthalmology2412-87402018-04-01271010.31288/oftalmolzh/2018/2/710Pathogenetic treatment for neurotrophic keratopathy T. B. Gaidamaka0T. A. Veliksar1G. I. Drozhzhyna2T. M. Serebrina3Filatov Institute of Eye Diseases and Tissue TherapyFilatov Institute of Eye Diseases and Tissue TherapyFilatov Institute of Eye Diseases and Tissue TherapyFilatov Institute of Eye Diseases and Tissue TherapyIntroduction. Continuous soft contact lens (SCL) wearing can result in development of neurotrophic keratopathy. Treatment of this pathology is long-term and, in general, symptomatic: tear-substitute, epithelizing, vitaminous, antibacterial, anti-inflammatory therapy. Purpose. To improve a correction method for metabolic alterations in corneal tissues in continuous-SCL-wear-associated neurotrophic keratopathy through using transorbital electrophoresis with 1% thiotriazoline. Material and Methods. We developed a method of treatment for neurotrophic keratopathy which includes a 10 day course of daily transorbital electrophoresis with 1% thiotriazoline as a part of complex therapy. We applied for approval of Author's certificate (application No U 201710621 dated 01 November 2017). Results. Clinical cases of treatment of stage 1 neurotrophic keratopathy are reported. Conclusion. The proposed treatment enables in a short term to significantly decrease pathological changes in corneal tissues in stage 1 neurotrophic keratopathy, to increase comfort in the eyes, to prevent severe complications of neurotrophic keratopathy and soft contact lens wearing. https://www.ozhurnal.com/en/archive/2018/2/2-fulltextneurotrophic keratopathycontact lensesthiotriazolineelectrophoresis |
| spellingShingle | T. B. Gaidamaka T. A. Veliksar G. I. Drozhzhyna T. M. Serebrina Pathogenetic treatment for neurotrophic keratopathy Journal of Ophthalmology neurotrophic keratopathy contact lenses thiotriazoline electrophoresis |
| title | Pathogenetic treatment for neurotrophic keratopathy |
| title_full | Pathogenetic treatment for neurotrophic keratopathy |
| title_fullStr | Pathogenetic treatment for neurotrophic keratopathy |
| title_full_unstemmed | Pathogenetic treatment for neurotrophic keratopathy |
| title_short | Pathogenetic treatment for neurotrophic keratopathy |
| title_sort | pathogenetic treatment for neurotrophic keratopathy |
| topic | neurotrophic keratopathy contact lenses thiotriazoline electrophoresis |
| url | https://www.ozhurnal.com/en/archive/2018/2/2-fulltext |
| work_keys_str_mv | AT tbgaidamaka pathogenetictreatmentforneurotrophickeratopathy AT taveliksar pathogenetictreatmentforneurotrophickeratopathy AT gidrozhzhyna pathogenetictreatmentforneurotrophickeratopathy AT tmserebrina pathogenetictreatmentforneurotrophickeratopathy |